Risks to the Fetus of Anticoagulant Therapy During Pregnancy
The DOI matches its Crossref record; 171 of the 172 references it cites were found in a registry or an index.
Abstract
Summary: The use of anticoagulants during pregnancy is problematic because of the potential adverse effects to the mother and the fetus. Heparin does not cross the placenta, and thus, it was surprising that a recent report concluded that heparin therapy during pregnancy was as risky as oral anticoagulant therapy. Therefore, we performed a literature review of fetal/infant outcomes following anticoagulant therapy during pregnancy. We examined 186 reports which described fetal/infant outcomes in 1,325 pregnancies associated with anticoagulant therapy. The rates of adverse fetal/infant outcomes including death, prematurity and congenital malformations following treatment with heparin, oral anticoagulants, or both were calculated. The previously described high rate of adverse feta/infant outcomes with heparin- treated patients, could be accounted for by the frequent use of heparin in pregnancies with comorbid conditions independently associated with adverse outcomes and by reports of uncomplicated prematurity. After excluding such pregnancies, outcomes in heparin-treated patients are similar to the normal population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Heparin does not cross the placenta and hence there is no potential to cause fetal haemorrhage or teratogenicity.170”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [170]
Citations
Cites
Maternal and fetal sequelae of anticoagulation during pregnancy
Hall, J. G., Pauli, R. M., & Wilson, K. M. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90181-3 · Cited by 997
Risks of Anticoagulant Therapy in Pregnant Women with Artificial Heart Valves
Iturbe-Alessio, I., Fonseca, M. D. C., Mutchinik, O., Santos, M. A., Zajarías, A., & Salazar, E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611273152205 · Cited by 307
Vellenga, E., Imhoff, G. W. V., & Aarnoudse, J. G. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90209-x · Cited by 265
Congenital malformations associated with the administration of oral anticoagulants during pregnancy
Lietman, P. S., Pettifor, J. M., & Benson, R. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80986-3 · Cited by 204
Thromboembolic disease in pregnancy
Villasanta, U. (1965) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(65)90308-x · Cited by 174
Hazards of Oral Anticoagulants During Pregnancy
Stevenson, R. E. (1980) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1980.03300410037022 · Cited by 172
Placental transport of heparin
Flessa, H. C., Kapstrom, A. B., Glueck, H. I., & Will, J. J. (1965) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(65)90518-1 · Cited by 165
Hellgren, M., Tengbom, L., & Abildgaard, U. (1982) · Gynecologic and Obstetric Investigation · doi:10.1159/000299460 · Cited by 158
The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial
Howell, R. J. S., Fidler, J., Letsky, E. A., & de Swiet, M. (1983) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1983.tb06458.x · Cited by 153
Is warfarin sodium contraindicated in the lactating mother?
McKenna, R., Cole, E. R., & Vasan, U. (1983) · The Journal of Pediatrics · doi:10.1016/s0022-3476(83)80378-3 · Cited by 145
Cited by
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (1998) · Chest · doi:10.1378/chest.114.5_supplement.489s · Cited by 1,031
Self-citationVenous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S., & Hirsh, J. (2008) · Chest · doi:10.1378/chest.08-0761 · Cited by 793
Self-citationChan, W. S., Anand, S., & Ginsberg, J. S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.2.191 · Cited by 749
Self-citationUse of Antithrombotic Agents During Pregnancy
Ginsberg, J. S., & Hirsh, J. (1995) · Chest · doi:10.1378/chest.108.4_supplement.305s · Cited by 657
Self-citation
Metadata
- Authors
- Ginsberg, J. S., Hirsh, J., Turner, D. C., Levine, M. N., & Burrows, R.
- Affiliations
- McMaster University (CA)
- ORCID
- Levine, Mark N
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 1989
- Volume
- 61
- Issue
- 02
- Pages
- 197-203
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W81044964
- Cited by
- 218
- References
- 172
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2021: 3 · 2020: 2 · 2019: 6 · 2018: 2 · 2017: 5 · 2016: 6 · 2015: 4 · 2014: 4 · 2013: 7 · 2012: 7
- FWCI
- 8.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- heparin, oral anticoagulants, fetal outcomes, infant outcomes, preterm birth, congenital malformations, fetal death, placental transfer, maternal comorbidities
- MeSH terms
- Anticoagulants, Female, Fetus, Heparin, Humans, Maternal-Fetal Exchange, Pregnancy, Pregnancy Complications, Hematologic, Pregnancy Outcome, Risk Factors, Thromboembolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risks to the Fetus of Anticoagulant Therapy During Pregnancy. https://app.cochat.ai/papers/10.1055/s-0038-1646558
- The paper
- Ginsberg, J. S., Hirsh, J., Turner, D. C., Levine, M. N., & Burrows, R. (1989). Risks to the Fetus of Anticoagulant Therapy During Pregnancy. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0038-1646558
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.